251 results
Page 4 of 13
8-K
EX-99.1
sgh mkqtr4cvea4
8 May 23
Alkermes Files Preliminary Proxy Statement and Provides Update on Annual Director Nomination Process
5:08pm
PREC14A
mfdh9s
8 May 23
Preliminary proxy with contested solicitation
4:34pm
8-K
EX-99.1
3d09nm81ifugknb4vkk
26 Apr 23
Alkermes plc Reports First Quarter 2023 Financial Results
7:05am
8-K
EX-99.2
v7mcoby 5sflrdovs
26 Apr 23
Alkermes plc Reports First Quarter 2023 Financial Results
7:05am
8-K
b7518 jzn
25 Apr 23
Alkermes Announces Second Interim Award in Janssen Pharmaceutica Arbitration
7:07am
8-K
EX-99.1
0v83ktt7
25 Apr 23
Alkermes Announces Second Interim Award in Janssen Pharmaceutica Arbitration
7:07am
8-K
EX-99.2
qx5ijka
2 Nov 22
Alkermes plc Reports Third Quarter 2022 Financial Results
7:06am
8-K
EX-99.3
4c4f8a5aya8i3sl1o bu
2 Nov 22
Alkermes plc Reports Third Quarter 2022 Financial Results
7:06am
8-K
EX-99.1
9nhic1f
2 Nov 22
Alkermes plc Reports Third Quarter 2022 Financial Results
7:06am
S-8
EX-5.1
5nhe2p83e7sc4r0mq85m
27 Jul 22
Registration of securities for employees
4:06pm
8-K
EX-99.1
n06qo9
27 Jul 22
Alkermes plc Reports Second Quarter 2022 Financial Results
7:05am
8-K
EX-99.2
uv7wgr
27 Jul 22
Alkermes plc Reports Second Quarter 2022 Financial Results
7:05am
8-K
EX-99.1
bsa4h
7 Jul 22
Alkermes Announces Results of Annual General Meeting of Shareholders
5:20pm
DEFC14A
1gz2dyem18irdbb9g gw
6 Jun 22
Proxy in contested solicitation
5:29pm
DEFA14A
EX-99.1
na8l6
26 May 22
Additional proxy soliciting materials
6:15pm
8-K
EX-99.1
ioljdmsu3tro0s1
26 May 22
Alkermes Announces Continued Board Refreshment, Including the Appointment of Christopher I. Wright, M.D., Ph.D. to its Board of Directors
6:09pm
PREC14A
y3ysa6
26 May 22
Preliminary proxy with contested solicitation
5:29pm